Global Jet Lag Therapy Treatment Market By Application (Business Travelers, Cabin Crew, Athletes, Seasonal Travelers and Others), Treatment Type (Sunlight, Bright Light Therapy, Melatonin Supplements, Sleeping Pills, Exercise and Others), Drugs (Nonbenzodiazepines, Benzodiazepines and Others), Route of Administration (Oral and Injectable) End-Users (Hospitals, Homecare, Specialty Clinics, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026
Market Analysis: Global Jet Lag Therapy Treatment Market
Global jet lag therapy treatment market is rising gradually with a substantial CAGR in the forecast period of 2019-2026. Rise in number of travelers who are traveling to different time zones and increase demand of disease specific treatment are the key factors for market growth.
Market Definition: Global Jet Lag Therapy Treatment Market
Jet lag also known as jet disorders or desynchronosis is a temporary condition of circadian rhythm sleep disorder which occurs when anyone travel across multiple time zones. Jet lag is caused when the natural biological clock of the body does not correlate with the local time zone. In jet lag disorders can demand for sleep during the day time in the new local time zone and stay awake, during late night usually when it is supposed to sleep. Jet lag may lead to fatigue, disturbance of bowel function, trouble falling asleep and tiredness.
- Exposure to high altitudes and cabin pressures associated with air travel act as drivers to the market growth
- Changes in the working shift timings associated with night shifts is also expected to drive this market growth
- New launches of insomnia related products annually can boost the market growth
- Rise in number of travelers who are traveling to different time zones is propelling the market growth
- Preference of non-pharmacological therapies over pharmacological therapies are hindering the market growth
- Introduction of alternative therapy to beat the jet lag disorders is restraining the market growth
- Limited efficacy rate of available intervention is expected to restrain the growth of the market
Segmentation: Global Jet Lag Therapy Treatment Market
- Business Travelers
- Cabin Crew
- Seasonal Travelers
By Treatment Type
- Bright Light Therapy
- Melatonin Supplements
- Sleeping Pills
By Route of Administration
By End Users
- Specialty Clinics
- North America
- South America
- Rest of South America
- United Kingdom
- Rest of Europe
- South Korea
- Rest of Asia Pacific
- Middle East & Africa
- South Africa
- Rest of Middle East & Africa
Key Developments in the Market:
In June 2019, Clinigen Group plc received marketing authorization for Melatonin oral solution and Melatonin film coated tablet from the Medicines and Healthcare products Regulatory Agency both forms are used for the treatment of short-term treatment of jet-lag in adults. This approval will ensure efficacy and reliable treatment for patients experiencing jet lag
In December 2018, Vanda Pharmaceuticals Inc received the FDA’s acceptance for supplemental New Drug Application (sNDA) for Hetlioz (tasimelteon), melatonin receptor agonist for the treatment of jet lag disorders. It has been already approved for Non-24-Hour Sleep-Wake Disorder. If approved, it will be beneficial for those whose sleep pattern interrupted by a jet lag
Global jet lag therapy treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of global jet lag therapy treatment market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Key Market Players:
Few of the major competitors currently working in the global jet lag therapy treatment market are Clinigen Group plc, Vanda Pharmaceuticals, Pfizer Inc, Jamieson Laboratories Ltd., NOW Foods, Nature’s Bounty, ALEXZA, Jazz Pharmaceuticals, Inc, Eisai Co., Ltd, Purdue Pharma L.P. and others.
Research Methodology: Global Jet Lag Therapy Treatment Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.
Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.
Reasons to Purchase this Report
- Current and future of global jet lag therapy treatment market outlook in the developed and emerging markets
- The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
- Regions/Countries that are expected to witness the fastest growth rates during the forecast period
- The latest developments, market shares, and strategies that are employed by the major market players